Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways-Reference-Cited by-同舟云学术

Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways

Published:2024-04 Issue: Volume:169 Page:106530
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Cheng Hai-peng,Bao Xing-wen,Luo Yong-yu,Li Yang-hang,Zhou Yan,Hua Qing-zhong,Qiu Yu-jia,Liang Xin-yue,Huang Yan-hong,Liu Wei,Tang Si-yuan,Feng Dan-dan,Li Chen,Luo Zi-qiang

Funder

Xiangya Hospital, Central South University

National Natural Science Foundation of China

Natural Science Foundation of Hunan Province

Publisher

Elsevier BV

Reference55 articles.

1. Nrf2 signaling pathway: Pivotal roles in inflammation;Ahmed;Biochim. Et. Biophys. Acta Mol. Basis Dis.,2017

2. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality;Al-Kuraishy;Int. Immunopharmacol.,2022

3. High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons;Al-Kuraishy;Inflammopharmacology,2022

4. The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome;Aranda-Valderrama;Int Anesth. Clin.,2018

5. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo;Bozinovski;J. Biol. Chem.,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum to “Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways” Int. J. Biochem. Cell Biol. 169 (2024) 106530.;The International Journal of Biochemistry & Cell Biology;2024-07

2. Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches;Drug Design, Development and Therapy;2024-06